Instrument Inactif

Communiqués Avivagen Inc Other OTC

Actions

CA05382F1036

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

2023	Avivagen Inc. annonce une nouvelle commande de 500 kg pour OxC-beta	CI
2023	Avivagen Inc. déclare ses résultats pour le troisième trimestre et les neuf mois terminés le 31 juillet 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	24/04	NE
Canadian Investment Regulatory Organization Trading Halt - VIV	06/03	AQ
Avivagen Announces Significant Increase in Sales to an Existing Customer	26/05/23	AQ
Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth	22/02/23	AQ
Avivagen Announces Foundational Scientific and Commercial Evidence of OxC-Beta Product Published in Peer-Reviewed Journal	20/01/23	AQ
Avivagen Inc. Announces Securities for Service Agreements With CEO and CSO	23/12/22	AQ
Avivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares	01/11/22	AQ
Avivagen Announces New Dairy Customer in Mexico	22/08/22	AQ
Avivagen : Announces Receipt of Repeat Order from Asian Customer	11/08/22	PU
Avivagen : Announces Significant Order of OxC-betaTM in Brazil	03/08/22	PU
Avivagen : 2022 Q2 MD&A 2022 04 30	17/06/22	PU
Avivagen : 2022 Q2 Financial Statements 2022 04 30	17/06/22	PU
Avivagen : Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene (OxBC)	09/06/22	PU
Avivagen : Signs New Distribution Partner in Vietnam to Support Southeast Asian Growth	30/05/22	PU
Avivagen Announces Approval in China, the World's Largest Commercial Feed Production Market	13/05/22	AQ
Avivagen : Announces Approval in China, the World’s Largest Commercial Feed Production Market	12/05/22	PU
Avivagen : Announces AGM Results and Update to Shareholders Record Year of Progress for OxC-betaTM Adoption Worldwide	08/04/22	PU
Avivagen to Attend CEM Sponsored Alpha North Conference	23/03/22	AQ
Avivagen : Announces Approval in Vietnam	22/02/22	PU
Avivagen Announces Appointment of James Nickerson as President	25/01/22	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Avivagen Inc Other OTC

Actions

CA05382F1036

Communiqués

Filtres